Roxane Laboratories, Inc.

35 articles with Roxane Laboratories, Inc.

• Roxane Laboratories, Inc. Announces the Launch of Zaleplon Capsules CIV

  6/9/2008

• Roxane Laboratories, Inc. Announces the Launch of Acarbose Tablets

  5/8/2008

• Roxane Laboratories Announces the Launch of Ropinirole Hydrochloride Tablets

  5/6/2008

• Roxane Laboratories Announces the Launch of Granisetron Hydrochloride Tablets, 1mg

  1/3/2008

• Roxane Laboratories Announces the Launch of Balsalazide Disodium Capsules, 750mg

  1/3/2008

• Roxane Laboratories Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg

  10/11/2007

• Roxane Laboratories Announces the Launch of Amlodipine Besylate Tablets, 2.5mg, 5mg, 10mg

  7/10/2007

• Roxane Laboratories Announces the Launch of Terbinafine Hydrochloride Tablets, 250mg

  7/3/2007

• Roxane Laboratories Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg

  4/24/2007

• District Court Calls for GlaxoSmithKline to Release Bond Amount of $3 Million to Roxane Laboratories Relating to the Launch of Generic Fluticasone Propionate

  4/11/2007

• Roxane Laboratories Announces The Launch Of Sertraline Hydrochloride Tablets, 25mg, 50mg, 100mg

  2/7/2007

• Urgent Notice-Drug Recall: Roxane Laboratories Initiates A Nationwide Voluntary Recall Of A Single Manufacturing Lot Of Azathioprine Tablets In The U.S. And Puerto Rico

  7/13/2006

• Roxane Laboratories Resumes Shipments Of Fluticasone Propionate Nasal Spray, 50 Mcg

  3/7/2006

• US FDA Approves First Generic Version Of GlaxoSmithKline's Allergy Spray

  2/23/2006

• Roxane Laboratories Drops Drug Access Lawsuit And Settles Litigation With State Of Texas

  11/29/2005